Stemirna

About:

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Website: http://www.stemirna.com/

Top Investors: OrbiMed, WuXi AppTec, HongShan, Forebright Capital, CITIC Securities

Description:

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Total Funding Amount:

1.33B CNY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2016-05-01

Contact Email:

info(AT)stemirna.com

Founders:

Hangwen Li

Number of Employees:

11-50

Last Funding Date:

2023-05-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai